Rupture of aneurysm of the middle cerebral artery along with stenosis of the internal carotid and coronary arteries
Authors: Kazantsev A. , Tarasov R. , Chernykh K. , Leader R. , Zarkua N. , Bagdavadze G. , Linets Yu. 
Published: July 2020

This article presents the results of treatment of a patient with rupture of a giant intracerebral aneurysm of the left middle cerebral artery (MCA), hemodynamically significant stenosis of the internal carotid artery on the left and the trunk of the left coronary artery with multiple lesions of the coronary arteries (anterior descending artery, diagonal branch, right coronary artery). A phased surgical correction was performed, with the time period between stages being 2 months, as follows:Stage 1 — open microsurgical clipping of the aneurysm of the left MCA and removal of intracerebral hematoma. The usage of the standard treatment volume in the form of 3H therapy (hypertension, haemodilution and hypervolemia), as well as slow calcium channel blockers in the postoperative period, was associated with a high risk of developing cardiovascular complications due to the presence of occlusal–stenotic lesions of the coronary and brachiocephalic channels. In the postoperative period, the patient received antiplatelet therapy (acetylsalicylic acid 100 mg at lunch), lipid-lowering therapy (rosuvastatin 20 mg in the evening) and anti-hypertensive therapy (bisoprolol 2.5 mg in the morning; perindopril 2.5 mg in the evening; spironolactone 25 mg in the morning; torasemide 10 mg in the morning; valparin XP 500 mg 2 times a day). On day 14, the patient was transferred from the intensive care unit, and on day 20, the patient was discharged from the hospital in satisfactory condition.Stage 2 — a combined operation in the amount of carotid endarterectomy (CEE) with plastic surgery of the biological patch on the left with plastic reconstruction of the reconstruction zone with a patch from the xenopericardium and coronary bypass grafting (CABG). Tactics were confirmed as optimal, taking into account the stratification of the risk of complications in the postoperative period when applying the new interactive program ‘Program support for the decision-making process for choosing a surgical re-vascularisation strategy for multifocal atherosclerosis’ (certificate of registration of a computer program RU 2017619457). Brain protection during CEE was achieved by invasive measurement of retrograde pressure (60 % of systemic blood pressure (BP)) and intraoperative increase in blood pressure to 180/90 mm Hg. CABG was performed using cardiopulmonary bypass. An epiaortic ultrasound scan was used to select the position of the implantation of a venous shunt into the aortic wall. Intraoperative flowmetry was used to regulate the quality of the implanted shunts.The patient was discharged 10 days after the surgery from the hospital in satisfactory condition. Conservative therapy, initiated after stage 1 of re-vascularisation, was continued.Clipping of intracerebral arterial aneurysm during its rupture and reconstructive interventions on the internal carotid artery and coronary arteries could be performed combined with the possibility of endovascular correction. However, due to the presence of an unstable atherosclerotic plaque, the possibility of interventional correction of the internal carotid artery was excluded, and the condition of the coronary bed at the time of stage 1 remained unknown. An additional argument in favour of open microsurgical clipping of the aneurysm was the need for the removal of intracerebral hematoma.The treatment strategy chosen here was found to be safe and effective. Satisfactory outcome of the surgery was achieved due to a complete range of perioperative examinations. The implemented tactics prevented the development of complications. The data obtained here would form the basis for the development of recommendations for selecting the optimal tactics of re-vascularisation in combined lesions of intracranial, extracranial and coronary arteries.
Received 21 April 2020. Revised 27 April 2020. Accepted 28 April 2020.
Funding: The study did not have sponsorship.
Conflict of interest: Authors declare no conflict of interest.
Author contributionsConception and design: А.N. Kazantsev, R.S. TarasovLiterature review: K.P. Chernykh, N.E. Zarkua, R.Y. Leader, G.Sh. BagdavadzeDrafting the article: А.N. KazantsevIllustrations: А.N. Kazantsev, K.P. Chernykh, N.E. Zarkua, R.Y. Leader, G.Sh. BagdavadzeCritical revision of the article: N.E. Zarkua, R.S. Tarasov, Y.P. LinetsFinal approval of the version to be published: А.N. Kazantsev, R.S. Tarasov, K.P. Chernykh, N.E. Zarkua, R.Y. Leader, G.Sh. Bagdavadze, Y.P. Linets